HomeAbout usHospitalsSearchLogin
Your medical data, safe and secure.
Name
AM103
Description
AM103 is a novel inhibitor of 5-lipoxygenase-activiting protein (FLAP) that has demonstrated potential to treat asthma and cardiovascular disease by preventing the synthesis of LT, which triggers inflammation. It is being developed by Amira.
No brand information found.
